Astrana Health Inc. (ASTH)
Astrana Health, Inc. (ASTH) Q2 Earnings Top Estimates
Astrana Health, Inc. (ASTH) came out with quarterly earnings of $0.4 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.19 per share a year ago.
Astrana Health Q2 Earnings Call Highlights
Astrana Health NASDAQ: ASTH reported second-quarter 2026 revenue of $973 million, up 49% from a year earlier, while adjusted EBITDA increased 43% to $69 million. Adjusted diluted earnings per share reached a record $0.80, up 45% year over year, as the company cited growth in value-based care arrangements, medical-cost management, Prospect Health acquisition synergies and operating leverage.
Astrana Health, Inc. (ASTH) Surges 7.3%: Is This an Indication of Further Gains?
Astrana Health, Inc. (ASTH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Astrana Health Says Prospect Deal Is Ahead of Schedule as Q1 Trends Beat Expectations
Astrana Health NASDAQ: ASTH CEO and President Brandon Sim said the value-based care company is seeing early benefits from its acquisition of Prospect, while reporting stronger-than-expected first-quarter trends across medical costs, free cash flow and revenue.
Astrana Health, Inc. (ASTH) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Astrana Health, Inc. (ASTH) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Astrana Health, Inc. (ASTH) Q1 2026 Earnings Call Transcript
Astrana Health, Inc. (ASTH) Q1 2026 Earnings Call Transcript
Astrana Health, Inc. (ASTH) Surpasses Q1 Earnings and Revenue Estimates
Astrana Health, Inc. (ASTH) came out with quarterly earnings of $0.74 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.14 per share a year ago.
Is the Options Market Predicting a Spike in Astrana Health Stock?
Investors need to pay close attention to ASTH stock based on the movements in the options market lately.
Astrana Health: A Delegated Risk Model At A Discount
Astrana Health, Inc. offers a mispriced growth opportunity, combining 20–30% top and bottom line growth with strong free cash flow and operational leverage. ASTH's risk-bearing, tech-enabled model drives industry-leading G&A efficiency (6.8%), diversified revenue streams, and resilience against reimbursement or membership volatility. Despite 56% revenue growth and robust EBITDA expansion, ASTH trades at deep valuation discounts (EV/Revenue 0.43x, EV/EBITDA 6.43x), reflecting over-discounted risk.
Astrana Health, Inc. (ASTH) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Astrana Health, Inc. (ASTH) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Astrana Health, Inc. (ASTH) Q4 2025 Earnings Call Transcript
Astrana Health, Inc. (ASTH) Q4 2025 Earnings Call Transcript
Astrana Health, Inc. (ASTH) Q4 Earnings and Revenues Surpass Estimates
Astrana Health, Inc. (ASTH) came out with quarterly earnings of $0.54 per share, beating the Zacks Consensus Estimate of $0.15 per share. This compares to a loss of $0.15 per share a year ago.
